Lack of adherence to follow-up visits after bariatric surgery: reasons and outcome.

BACKGROUND: A substantial number of patients undergoing bariatric surgery are lost to follow-up for unknown reasons, which may cause an overestimation of the benefits of operation. The aim of this study was to identify the reasons of failure to attend controls after bariatric surgery and the relationship with poor weight loss. METHODS: A retrospective analysis of a prospective database including all patients undergoing bariatric surgery from January 2004 to February 2012 was performed. Nonadherence was defined as missing any scheduled control visit for more than 6 months. Contact was attempted (mail, telephone, and e-mail), and responders were requested to complete a questionnaire. RESULTS: Forty-six (17.5%) out of 263 patients were considered nonadherent. Thirty-three (71.7%) of these patients completed the questionnaire. The main reasons for nonadherence were work- (36.4%) and family-related (18.2%) problems or having moved outside the city or to the country (15.2%). The percentage of nonadherent patients aged ≤45 years was greater as compared with those aged >45 years [28 (60.1%) vs 18 (42.2%), respectively, P = 0.034]. Likewise, of the 30 patients with unsuccessful weight loss (<50% EWL), seven (30.4%) were in the nonadherent group while 23 (10.6%) in the adherent group (P = 0.046). Finally, 96.9% of patients were completely satisfied with surgery and would recommend the procedure to other morbid obese patients. CONCLUSION: The nonadherence rate to follow-up visits after bariatric surgery was 17.5%, mainly associated with work-related problems. Nonadherence was greater in patients aged ≤45 years and in those with poor weight loss.

Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the most common bariatric technique. Laparoscopic sleeve gastrectomy (LSG) is a restrictive procedure; the metabolic and endocrine effects of which remain unknown. We compared the effects of both procedures on glucose metabolism and fasting and meal-stimulated gut hormone levels. METHODS: Seven patients were randomised to LRYGB and eight to LSG. All patients were evaluated before and at 3 and 12 months postoperatively. Plasma levels of glucose, insulin, ghrelin, leptin, peptide YY (PYY), GLP-1 and pancreatic polypeptide were measured before and after 10 and 60 min of a standard test meal ingestion. RESULTS: Age, body mass index and preoperative hormone levels were similar in both groups. A significant reduction of plasma glucose and insulin levels was observed after surgery. Moreover, a normalisation of homeostatic model assessment for insulin resistance value was also seen after both procedures. The fasting and postprandial leptin levels were significantly lower in the LRYGB group. LSG was followed by a significant reduction in fasting ghrelin levels. In the LRYGB group, GLP-1 levels increased significantly after the test meal. CONCLUSIONS: LRYGB and LSG markedly improved glucose homeostasis. Only LSG decreased fasting and postprandial ghrelin levels, whereas GLP-1 and PYY levels increased similarly after both procedures.

Pérdida de masa ósea tras gastrectomía tubular: estudio prospectivo comparativo con el bypass gástrico / Bone mass loss after sleeve gastrectomy: A prospective comparative study with gastric bypass

Introducción: La cirugía bariátrica es la opción más eficaz para el tratamiento de los pacientes con alto riesgo de complicaciones por su obesidad. Sin embargo provoca una serie de alteraciones metabólicas sobre el calcio y la vitamina D y un aumento de la resorción que conllevan una pérdida de masa ósea. Objetivo: El objetivo del estudio es la comparación de la gastrectomía tubular (GT) con el bypass gástrico en Y de Roux (BGYR) respecto la pérdida de masa ósea medida mediante densitometría y marcadores de remodelado óseo. Pacientes y métodos: Se incluyeron 15 mujeres con obesidad mórbida, 8 en la GT y 7 en el BGYR, de edad media 47,8±9 con un índice de masa corporal 43,3±3,4. Se realizaron mediciones de la masa ósea a nivel de columna, fémur y tercio distal del radio y marcadores de remodelado óseo N-telopéptido (NTx), y fosfatasa alcalina específica ósea (FAO), así como niveles de vitamina D antes y a los 12 meses de la intervención. Resultados: Se observó una pérdida significativa de masa ósea con la GT y el BGYR, en columna lumbar y cadera mientras que en el radio no se observaron diferencias significativas. El porcentaje de pérdida de masa ósea fue menor en columna y fémur tras la GT que con el BGYR, aunque sin llegar a la significación estadística, 4,6&%#x000B1;4,4 (media±DE) y 6,3&%#x000B1;5,4 (media±DE) respectivamente. A los 12 meses el NTx aumentó para ambos tipos de intervención y las FAO aumentaron solo para la GT. Conclusión: La GT provoca una pérdida menor de masa ósea, aunque no significativa, respecto el BGYR (AU)

Introduction: Bariatric surgery is the most effective option for the treatment of patients with a high risk of complications due to their obesity. However, it brings about a series of changes in calcium and vitamin D metabolism and an increase in resorption which lead to a loss of bone mass. Aim: The objective of this study is to compare sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) as regards loss of bone mass using bone densitometry and bone remodelling markers. Patients and methods: Fifteen women with morbid obesity were included, 8 by SG and 7 by RYGB, with a mean age of 47.8±9 and mean body mass index 43.3±3.4. Bone mass measurements were made on the lumbar spine, femur and distal radius, and the bone remodelling markers N-telopeptide (NTx) and bone alkaline phosphatase (BALP), as well as vitamin D levels before and 12 months after surgery. Results: A significant bone mass loss was observed was observed with SG and RYGB, in the lumbar spine and hip, whilst no differences were observed in the radial. The percentage bone mass loss was less in the column and femur after SG than with RYGB, although it did not reach statistical significance, 4.6&%#x000B1;4.4 (mean±SD) and 6.3&%#x000B1;5.4 (mean±SD), respectively. At 12 months the Ntx increased for both types of surgery, and the BAP was only increased for SG. Conclusion: SG causes less, although not significant, bone mass loss compared to RYGB (AU)

[Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass]. / Pérdida de masa ósea tras gastrectomía tubular: estudio prospectivo comparativo con el bypass gástrico.

INTRODUCTION: Bariatric surgery is the most effective option for the treatment of patients with a high risk of complications due to their obesity. However, it brings about a series of changes in calcium and vitamin D metabolism and an increase in resorption which lead to a loss of bone mass. AIM: The objective of this study is to compare sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) as regards loss of bone mass using bone densitometry and bone remodelling markers. PATIENTS AND METHODS: Fifteen women with morbid obesity were included, 8 by SG and 7 by RYGB, with a mean age of 47.8+/-9 and mean body mass index 43.3+/-3.4. Bone mass measurements were made on the lumbar spine, femur and distal radius, and the bone remodelling markers N-telopeptide (NTx) and bone alkaline phosphatase (BALP), as well as vitamin D levels before and 12 months after surgery. RESULTS: A significant bone mass loss was observed was observed with SG and RYGB, in the lumbar spine and hip, whilst no differences were observed in the radial. The percentage bone mass loss was less in the column and femur after SG than with RYGB, although it did not reach statistical significance, 4.6%+/-4.4 (mean+/-SD) and 6.3%+/-5.4 (mean+/-SD), respectively. At 12 months the Ntx increased for both types of surgery, and the BAP was only increased for SG. CONCLUSION: SG causes less, although not significant, bone mass loss compared to RYGB.